Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients.

@article{Filmont2003ConventionalIA,
  title={Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients.},
  author={J. -E. Filmont and Duska Vranjesevic and Andrew Quon and Daniel J. A. Margolis and Fred Chau-Yang Ko and Arash Safaei and Christos Emmanouilides and Daniel H. S. Silverman and Jyotsna Eleshwarapu Rao and P. Valk and Michael E. Phelps and Johannes G Czernin},
  journal={Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging},
  year={2003},
  volume={5 4},
  pages={232-9}
}
PURPOSE The aim of this study was to determine the impact of positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-D-glucose (FDG) and combined conventional imaging on clinical stage and their ability to predict the clinical outcome of previously treated lymphoma patients. PROCEDURES Seventy-eight patients with Non-Hodgkin's Lymphoma (NHL) were studied with PET within a median interval of 5.3 months after treatment. Conventional imaging performed after treatment and within three… CONTINUE READING

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…